India likely to get dengue vaccine by end of 2019

New Delhi: India is likely to get a vaccination for Dengue by the end of 2019.

Pharmaceutical giant Panacea Biotec has secured permissions to conduct a clinical trial in the country after the Drug Controller General of India permitted it to test the viability, as per media reports.

The clinical trials on humans will most probably begin by early 2018 and this vaccine will hopefully reduce the number of death cases along with cutting down the cost of treatment as well.

India saw an alarming rise in the number of dengue cases between 2015 and 2017.

In 2017, at least 216 people lost their lives to this lethal disease.

Reportedly, the trials are being facilitated in a speedy manner and it is being ensured that the vaccine is effective and safe for the people.

Dengue is a mosquito-borne disease which affects the blood, resulting in a drop of platelets, causing deaths in many cases.